Skip to content

Ultraflex Infusion Set

by Disetronic Medical Systems AG 510(k)

Active United States

510(k) K033892

Regulatory status

as of 28 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK033892 Date9 Mar 2004ClearedStatusActive

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Recalls

12 recalls · FDA

  • 11 recalls, same reason

    • Terminated Z-1118-06 FDA Unclassified (pre-2012) initiated 31 Mar 2006 on shared 510(k) K033892
    • Terminated Z-1120-06 FDA Unclassified (pre-2012) initiated 31 Mar 2006 on shared 510(k) K033892
    • Terminated Z-1125-06 FDA Unclassified (pre-2012) initiated 31 Mar 2006 on shared 510(k) K033892
    • Terminated Z-1119-06 FDA Unclassified (pre-2012) initiated 31 Mar 2006 on shared 510(k) K033892
    • Terminated Z-1117-06 FDA Unclassified (pre-2012) initiated 31 Mar 2006 on shared 510(k) K033892
    • Terminated Z-1127-06 FDA Unclassified (pre-2012) initiated 31 Mar 2006 on shared 510(k) K033892
    • Terminated Z-1122-06 FDA Unclassified (pre-2012) initiated 31 Mar 2006 on shared 510(k) K033892
    • Terminated Z-1126-06 FDA Unclassified (pre-2012) initiated 31 Mar 2006 on shared 510(k) K033892
    • Terminated Z-1116-06 FDA Unclassified (pre-2012) initiated 31 Mar 2006 on shared 510(k) K033892
    • Terminated Z-1123-06 FDA Unclassified (pre-2012) initiated 31 Mar 2006 on shared 510(k) K033892
    • Terminated Z-1121-06 FDA Unclassified (pre-2012) initiated 31 Mar 2006 on shared 510(k) K033892

    The luer tube may break at the lock-tubing connection to the pump, causing an interruption of insulin delivery, which can and has contributed to hyperglycemia

    • Terminated Z-1124-06 FDA Unclassified (pre-2012) initiated 31 Mar 2006 on shared 510(k) K033892

    The luer tube may break at the connection to the pump and, if this is not noticed by the patient, the patient may receive an under delivery of insulin.

Recalls on a shared submission name another device cleared under the same FDA submission as this one.

Specification

510(k)

510(k) Number
FDA Product Code
FPA
Device Class
Class II
Regulation
21 CFR Part 880.5440
Advisory Committee
General Hospital
FDA Decision
SESE Substantially Equivalent

Other devices from Disetronic Medical Systems

See all devices from Disetronic Medical Systems →